Valuation: Oriola Oyj

Market Cap 17Cr 19Cr 15Cr 14Cr 27Cr 1.83TCr 27Cr 184.21Cr 72Cr 890.57Cr 71Cr 69Cr 3.09TCr P/E 2026 *
90x
P/E 2027 * 11.6x
Enterprise Value 10Cr 12Cr 9.72Cr 8.94Cr 17Cr 1.15TCr 17Cr 116.22Cr 45Cr 561.88Cr 45Cr 44Cr 1.95TCr EV / Sales 2026 *
0.5x
EV / Sales 2027 * 0.39x
Free-Float
67.86%
Yield 2026 *
2.78%
Yield 2027 * 5.56%
Manager TitleAgeSince
Chief Executive Officer 57 15/03/2022
Director of Finance/CFO 57 16/09/2024
Investor Relations Contact - -
Director TitleAgeSince
Chairman 60 01/01/2023
Director/Board Member 60 01/01/2024
Director/Board Member 57 01/01/2023
Change 5-day change 1-year change 3-year change Capi.($)
-4.65%-12.39% - - 19Cr
+1.28%-2.00%+15.47%+99.55% 9.53TCr
+2.47%-1.20%+43.24%+142.86% 5.17TCr
-0.69%-2.05%+3.61%+250.00% 2.33TCr
-0.96%-1.66%-13.50%-18.68% 829.3Cr
-1.33%-3.31%-30.90%-30.77% 797.64Cr
-0.35%-2.98%-11.27%-29.46% 676.25Cr
-0.84%+2.81%+25.47%+27.58% 628.99Cr
-2.63%-0.11%-1.97%+20.46% 548.21Cr
0.00%-1.94%-6.47%-7.22% 372.59Cr
Average -0.67%+0.34%+2.63%+50.48% 2.32TCr
Weighted average by Cap. +0.94%+0.64%+16.69%+107.02%

Financials

2026 *2027 *
Net sales 21Cr 24Cr 19Cr 18Cr 33Cr 2.28TCr 34Cr 230.36Cr 90Cr 1.11TCr 89Cr 87Cr 3.86TCr 22Cr 25Cr 20Cr 19Cr 35Cr 2.39TCr 35Cr 241.54Cr 94Cr 1.17TCr 93Cr 91Cr 4.05TCr
Net income 13.8L 15.69L 12.82L 11.79L 22.11L 15Cr 22.51L 1.53Cr 59.8L 7.41Cr 58.91L 57.63L 26Cr 1.44Cr 1.63Cr 1.33Cr 1.23Cr 2.3Cr 158.01Cr 2.34Cr 16Cr 6.22Cr 77Cr 6.13Cr 5.99Cr 267.38Cr
Net Debt -6.12Cr -6.96Cr -5.69Cr -5.23Cr -9.81Cr -673.87Cr -9.98Cr -68Cr -27Cr -328.69Cr -26Cr -26Cr -1.14TCr -8.04Cr -9.14Cr -7.47Cr -6.87Cr -13Cr -885.28Cr -13Cr -89Cr -35Cr -431.8Cr -34Cr -34Cr -1.5TCr
Logo Oriola Oyj
Oriola Oyj, formerly known as Oriola-KD Corporation Oyj, is a Finland-based company active in the pharmaceutical sector. The Company is engaged in the retail and wholesale of pharmaceuticals, acting as a channel between pharmaceutical manufacturers and consumers, primarily in Finland and Sweden. The Company's reporting segments are Consumer, Services, and Healthcare. Through its own pharmacies, the Company provides consumers with not only medicines and pharmaceutical advice but also a selection of healthcare consumer products and customer service. The Company is active through a number of subsidiaries located throughout Europe, including PharmaService OY, Oriola AB, Oriola Oyj, Farenta Oy, Kronans Droghandel Apotek AB and Svensk dos AB.
Employees
796
Trader
Investor
Global
Quality
ESG MSCI
-